- Home
- MUA vs SIGA Comparison
MUA vs SIGA Comparison
Compare MUA & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$6.19
Company Overview
Basic Information| Metric | MUA | SIGA |
|---|---|---|
| Founded | 1993 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 414.4M | 462.6M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | MUA | SIGA |
|---|---|---|
| Price | $10.71 | $6.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 92.6K | ★ 334.4K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | 4.84% | ★ 9.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $172,249,641.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $132.36 |
| P/E Ratio | ★ N/A | $5.92 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.61 | $4.95 |
| 52 Week High | $11.43 | $9.62 |
Technical Indicators
Market Signals| Indicator | MUA | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 43.63 |
| Support Level | $10.58 | $6.08 |
| Resistance Level | $10.81 | $6.45 |
| Average True Range (ATR) | 0.16 | 0.15 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 28.05 | 27.17 |
Price Performance
Historical Comparison MUA
SIGA
About MUA Blackrock MuniAssets Fund Inc
Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations. The Fund invests more of its total assets in municipal bonds.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.